Clinical Research Division, Fred Hutch
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
Dr. Elizabeth Krakow pursues two primary areas of research. In one, she works to develop safe and effective cellular immunotherapy approaches for patients with leukemia and lymphomas, especially those who have relapsed after blood and marrow transplantation. She also uses traditional and novel statistical methods, such as machine learning, to analyze complex longitudinal data that could help select highly personalized, adaptive treatment strategies for cancers and for transplant complications. The goal is to optimize each sequential therapy for an individual patient, taking into account how that patient's attributes change over time, including the patient's response to prior treatments.
Associate Professor, Division of Hematology and Oncology
University of Washington
MSc, Epidemiology, McGill University, Montreal, 2015
Hematopoietic Cell Transplantation, Hôpital Maisonneuve-Rosemont and Université de Montréal, Montreal, Quebec, 2015
Hematology, McMaster University, Hamilton, Ontario, 2008
Internal Medicine, Duke University Medical Center, 2006
MD, CM, McGill University, Montreal, Quebec, 2003
Novel transplantation and cellular immunotherapy strategies
Adaptive treatment strategies in hematology/oncology/transplantation
— Dr. Elizabeth Krakow
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210